How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like 3 FDA Decisions to Look Out for in February January 31, 2018 FDA Approves Sanofi's Admelog, the First Follow-On Insulin to Control Sugar at Mealtime December 11, 2017 EnXray Raises ??2.3 Million To Fund Commercial Launch April 9, 2017
FDA Approves Sanofi's Admelog, the First Follow-On Insulin to Control Sugar at Mealtime December 11, 2017
